9 Analysts Have This To Say About Legend Biotech
9 Analysts Have This To Say About Legend Biotech
9位分析師對傳奇生物有這樣的看法
Analyzing...Across the recent three months, 9 analysts have shared their insights on Legend Biotech (NASDAQ:LEGN), expressing a variety of opinions spanning from bullish to bearish.
最近三個月裏，9位分析師就傳奇生物（納斯達克：LEGN）發表了自己的見解，意見各不相同，從看好到看淡不一。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
In the assessment of 12-month price targets, analysts unveil insights for Legend Biotech, presenting an average target of $77.67, a high estimate of $86.00, and a low estimate of $73.00. Marking an increase of 2.36%, the current average surpasses the previous average price target of $75.88.
在對12個月價格目標的評估中，分析師揭示了對傳奇生物的見解，提出了77.67美元的平均目標，86.00美元的高估值和73.00美元的低估值。當前平均目標較之前的75.88美元的平均目標增長了2.36%。
Analyzing...
分...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間